Difference between revisions of "Team:NTU-LIHPAO-Taiwan/Parts"
LesleyChiu (Talk | contribs) |
|||
(53 intermediate revisions by 2 users not shown) | |||
Line 67: | Line 67: | ||
body { | body { | ||
− | background-color: # | + | background-color: #FFF; |
} | } | ||
body,td,th { | body,td,th { | ||
Line 73: | Line 73: | ||
font-family: Calibri, "Arial Narrow", "Agency FB", "Raavi"; | font-family: Calibri, "Arial Narrow", "Agency FB", "Raavi"; | ||
} | } | ||
+ | |||
#Wrapper { | #Wrapper { | ||
margin-right: auto; | margin-right: auto; | ||
Line 80: | Line 81: | ||
margin-bottom: 0px; | margin-bottom: 0px; | ||
width: 90%; | width: 90%; | ||
− | height: | + | height: auto; |
top: 0px; | top: 0px; | ||
left: 5%; | left: 5%; | ||
right: 5%; | right: 5%; | ||
position: absolute; | position: absolute; | ||
+ | bottom: 0px; | ||
+ | padding-top: 0px; | ||
+ | padding-bottom: 0px; | ||
+ | z-index: 0; | ||
+ | } | ||
+ | |||
+ | #Wrapper_Left { | ||
+ | margin-right: auto; | ||
+ | margin-left: auto; | ||
+ | background-color: #F0F0F0; | ||
+ | margin-top: 0px; | ||
+ | margin-bottom: 0px; | ||
+ | width: 5%; | ||
+ | height: 100%; | ||
+ | top: 0px; | ||
+ | left: 0%; | ||
+ | right: auto; | ||
+ | position: fixed; | ||
+ | bottom: 0px; | ||
+ | padding-top: 0px; | ||
+ | padding-bottom: 0px; | ||
+ | z-index: 0; | ||
+ | } | ||
+ | |||
+ | #Wrapper_Right { | ||
+ | margin-right: auto; | ||
+ | margin-left: auto; | ||
+ | background-color: #F0F0F0; | ||
+ | margin-top: 0px; | ||
+ | margin-bottom: 0px; | ||
+ | width: 5%; | ||
+ | height: 100%; | ||
+ | top: 0px; | ||
+ | left: auto; | ||
+ | right: 0%; | ||
+ | position: fixed; | ||
bottom: 0px; | bottom: 0px; | ||
padding-top: 0px; | padding-top: 0px; | ||
Line 116: | Line 153: | ||
#Wrapper_Bottom { | #Wrapper_Bottom { | ||
width: 100%; | width: 100%; | ||
− | height: | + | height: 100px; |
bottom: 0px; | bottom: 0px; | ||
+ | top: auto; | ||
background-color: #FFF; | background-color: #FFF; | ||
+ | border-top-style: solid; | ||
+ | border-top-color: #079235; | ||
+ | border-top-width: 3px; | ||
margin-right: auto; | margin-right: auto; | ||
margin-left: auto; | margin-left: auto; | ||
margin-top: 0px; | margin-top: 0px; | ||
margin-bottom: 0px; | margin-bottom: 0px; | ||
− | |||
− | |||
− | |||
z-index: 9998; | z-index: 9998; | ||
− | + | position: absolute; | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
} | } | ||
Line 194: | Line 227: | ||
top: 32px; | top: 32px; | ||
bottom: 0px; | bottom: 0px; | ||
− | left: | + | left: 51%; |
right: 15%; | right: 15%; | ||
list-style:none; | list-style:none; | ||
Line 275: | Line 308: | ||
} | } | ||
− | + | .width_small { | |
width: 100px; /*--改主要選單寬度--*/ | width: 100px; /*--改主要選單寬度--*/ | ||
− | |||
− | |||
− | |||
− | |||
} | } | ||
Line 317: | Line 346: | ||
} | } | ||
− | # | + | #Content_Container { |
position: fixed; | position: fixed; | ||
− | |||
− | |||
width: 17.8%; | width: 17.8%; | ||
height: 100%; | height: 100%; | ||
+ | left: 5.2%; | ||
+ | right: auto; | ||
+ | background: #f7fbff; | ||
+ | z-index: 5; | ||
+ | } | ||
+ | |||
+ | #Content { | ||
+ | position: absolute; | ||
+ | top: 60px; | ||
+ | width: 100%; | ||
+ | height: auto; | ||
padding: 0; | padding: 0; | ||
margin: 0; | margin: 0; | ||
− | |||
transition: 0.5s; | transition: 0.5s; | ||
font-size: 0.8rem; | font-size: 0.8rem; | ||
− | |||
font-family: Calibri; | font-family: Calibri; | ||
} | } | ||
Line 347: | Line 383: | ||
position: absolute; | position: absolute; | ||
top: 5rem; | top: 5rem; | ||
− | left: | + | left: 10%; |
+ | width: 90%; | ||
} | } | ||
Line 360: | Line 397: | ||
padding-top: 5px; | padding-top: 5px; | ||
padding-bottom: 5px; | padding-bottom: 5px; | ||
+ | line-height: 30px; | ||
} | } | ||
Line 366: | Line 404: | ||
overflow-y: auto; | overflow-y: auto; | ||
transition: 0.5s; | transition: 0.5s; | ||
− | width: | + | width: 85%; |
− | + | left: 15%; | |
− | + | position: relative; | |
} | } | ||
.sub-Content > li { | .sub-Content > li { | ||
− | padding-top: | + | padding-top: 10px; |
− | padding-bottom: | + | padding-bottom: 10px; |
} | } | ||
Line 386: | Line 424: | ||
opacity: 0.5; | opacity: 0.5; | ||
} | } | ||
+ | |||
+ | #Healthin_Logo_Content { | ||
+ | width: 100%; | ||
+ | height: auto; | ||
+ | } | ||
+ | |||
+ | #Healthin_Logo { | ||
+ | top: 55px; | ||
+ | padding-left: 3%; | ||
+ | padding-right: 3%; | ||
+ | position: absolute; | ||
+ | width: 94%; | ||
+ | height: 94%; | ||
+ | } | ||
+ | |||
+ | |||
/*-------------------------------------------*/ | /*-------------------------------------------*/ | ||
Line 391: | Line 445: | ||
/*-------------------------------------------*/ | /*-------------------------------------------*/ | ||
− | . | + | .Container_Bottom1 { |
− | height: | + | height: 70px; |
width: 100%; | width: 100%; | ||
+ | } | ||
+ | |||
+ | .Container_Bottom2 { | ||
+ | height: 70px; | ||
+ | width: 100%; | ||
+ | padding-top: 10px; | ||
+ | border-top-style: solid; | ||
+ | border-top-color: #079235; | ||
+ | border-top-width: 3px; | ||
+ | } | ||
+ | |||
+ | .Intro_Picture { | ||
+ | width: 100%; | ||
+ | height: auto; | ||
background-color: #FFF; | background-color: #FFF; | ||
− | |||
position: absolute; | position: absolute; | ||
} | } | ||
− | . | + | #NTUschool_logo { |
+ | background-color: #FFF; | ||
+ | padding-left: 9.6%; | ||
+ | padding-right: 60.4%; | ||
+ | position: absolute; | ||
+ | width: 30%; | ||
+ | height: 100%; | ||
+ | } | ||
+ | |||
+ | #LIHPAO_logo { | ||
+ | background-color: #FFF; | ||
+ | padding-left: 66.4%; | ||
+ | padding-right: 9.6%; | ||
+ | position: absolute; | ||
+ | width: 24%; | ||
+ | height: 100%; | ||
+ | } | ||
+ | |||
+ | #NTUBST_logo { | ||
+ | background-color: #FFF; | ||
+ | padding-left: 49.2%; | ||
+ | padding-right: 43.2%; | ||
+ | position: absolute; | ||
+ | width: 7.6%; | ||
+ | height: 100%; | ||
+ | } | ||
+ | |||
+ | .Text_Sponsor { | ||
+ | color: #767676; | ||
+ | font-size: 15px; | ||
+ | font-family: Calibri; | ||
+ | text-align: center; | ||
+ | line-height: 20px; | ||
+ | } | ||
+ | |||
+ | |||
+ | /*-------------------------------------------*/ | ||
+ | /*---------------Article Picture-------------*/ | ||
+ | /*-------------------------------------------*/ | ||
+ | |||
+ | .Container_Article_Picture { | ||
height: 280px; | height: 280px; | ||
width: 100%; | width: 100%; | ||
Line 406: | Line 513: | ||
} | } | ||
− | . | + | .Article_Picture { |
− | width: | + | width: 480px; |
height: auto; | height: auto; | ||
left: 50%; | left: 50%; | ||
right: auto; | right: auto; | ||
background-color: #FFF; | background-color: #FFF; | ||
+ | margin: 0 0 0 -240px; | ||
position: absolute; | position: absolute; | ||
− | margin: 0 0 0 - | + | } |
+ | |||
+ | .Article_PictureText { | ||
+ | width: 430px; | ||
+ | height: auto; | ||
+ | padding-left: 25px; | ||
+ | padding-right: 25px; | ||
+ | border-top-width: 2px; | ||
+ | border-top-style: dashed; | ||
+ | border-top-color: #fe5838; | ||
+ | } | ||
+ | |||
+ | .Container_Article_Picture1 { | ||
+ | height: 400px; | ||
+ | width: 100%; | ||
+ | padding-top: 25px; | ||
+ | padding-bottom: 25px; | ||
+ | } | ||
+ | |||
+ | .Article_Picture1 { | ||
+ | width: 368px; | ||
+ | height: auto; | ||
+ | left: 50%; | ||
+ | right: auto; | ||
+ | background-color: #FFF; | ||
+ | margin: 0 0 0 -184px; | ||
position: absolute; | position: absolute; | ||
} | } | ||
− | . | + | .Article_PictureText1 { |
− | width: | + | width: 318px; |
height: auto; | height: auto; | ||
padding-left: 25px; | padding-left: 25px; | ||
Line 434: | Line 567: | ||
color: #08923a; | color: #08923a; | ||
} | } | ||
+ | |||
+ | |||
/*-------------------------------------------*/ | /*-------------------------------------------*/ | ||
/*-----------------Articles------------------*/ | /*-----------------Articles------------------*/ | ||
Line 439: | Line 574: | ||
#Articles { | #Articles { | ||
− | width: | + | width: 100%; |
− | height: | + | height: auto; |
− | + | ||
− | + | ||
top: -10px; | top: -10px; | ||
position: absolute; | position: absolute; | ||
background-color: #FFF; | background-color: #FFF; | ||
− | z-index: | + | z-index: 1; |
color: #000; | color: #000; | ||
} | } | ||
.ContentBox { | .ContentBox { | ||
− | width: | + | width: 76%; |
− | height: | + | height: auto; |
+ | left: 22%; | ||
+ | right: 2%; | ||
+ | position: absolute; | ||
+ | background-color: #FFF; | ||
} | } | ||
Line 505: | Line 642: | ||
font-style: italic; | font-style: italic; | ||
} | } | ||
+ | |||
+ | ol.part1 { | ||
+ | list-style-type: none; | ||
+ | margin-left: 0px; | ||
+ | } | ||
+ | |||
+ | ol.part2 { | ||
+ | list-style-type: decimal; | ||
+ | margin-left: 0px; | ||
+ | } | ||
+ | |||
+ | ol.part2 li { | ||
+ | padding-top: 10px; | ||
+ | padding-bottom: 10px; | ||
+ | } | ||
+ | |||
+ | ol.part3 { | ||
+ | list-style-type: lower-alpha; | ||
+ | } | ||
+ | |||
+ | |||
+ | /*-------------------------------------------*/ | ||
+ | /*-------------------Media-------------------*/ | ||
+ | /*-------------------------------------------*/ | ||
+ | |||
+ | @media screen and (min-width: 0px) and (max-width: 1200px) { | ||
+ | |||
+ | #NTUXLIHPAO_icon { | ||
+ | height: 40px; | ||
+ | width: 200px; | ||
+ | position: absolute; | ||
+ | left: 1%; | ||
+ | top: 18px; | ||
+ | right: auto; | ||
+ | bottom: auto; | ||
+ | z-index: 9999; | ||
+ | } | ||
+ | |||
+ | |||
+ | #width_small { | ||
+ | width: 95px; /*--改主要選單寬度--*/ | ||
+ | } | ||
+ | |||
+ | .Slidemenu { | ||
+ | z-index: 9999; | ||
+ | position: absolute; | ||
+ | top: 32px; | ||
+ | bottom: 0px; | ||
+ | left: 49%; | ||
+ | right: auto; | ||
+ | list-style:none; | ||
+ | margin:0; | ||
+ | padding:0; | ||
+ | position: absolute; | ||
+ | margin-left: -320px; | ||
+ | /*background:rgba(100%,100%,100%,0); 主選單色系選擇*/ | ||
+ | } | ||
+ | } | ||
+ | |||
+ | @media screen and (min-width: 901px) and (max-width: 1050px) { | ||
+ | |||
+ | .Container_Bottom2 { | ||
+ | height: 60px; | ||
+ | width: 100%; | ||
+ | padding-top: 10px; | ||
+ | border-top-style: solid; | ||
+ | border-top-color: #079235; | ||
+ | border-top-width: 3px; | ||
+ | } | ||
+ | } | ||
+ | |||
+ | @media screen and (min-width: 0px) and (max-width: 900px) { | ||
+ | |||
+ | .Container_Bottom2 { | ||
+ | height: 50px; | ||
+ | width: 100%; | ||
+ | padding-top: 10px; | ||
+ | border-top-style: solid; | ||
+ | border-top-color: #079235; | ||
+ | border-top-width: 3px; | ||
+ | } | ||
+ | } | ||
+ | |||
</style> | </style> | ||
Line 518: | Line 738: | ||
<body> | <body> | ||
− | <div id=" | + | <div id="Wrapper_Left"></div> |
− | + | <div id="Wrapper_Right"></div> | |
− | + | ||
− | + | ||
+ | <div id="Wrapper"> | ||
<div id="Wrapper_TopPic"> | <div id="Wrapper_TopPic"> | ||
<div id="NTUXLIHPAO_icon"><img src="https://static.igem.org/mediawiki/2015/c/c7/NTU-Top-NTUXLIHPAO.png" height="40" /></div> | <div id="NTUXLIHPAO_icon"><img src="https://static.igem.org/mediawiki/2015/c/c7/NTU-Top-NTUXLIHPAO.png" height="40" /></div> | ||
Line 534: | Line 753: | ||
<div class="Slidemenu"> | <div class="Slidemenu"> | ||
<ul> | <ul> | ||
− | <li><div | + | <li><div class=width_small><a href="https://2015.igem.org/Team:NTU-LIHPAO-Taiwan">Home</a></div> |
− | + | </li> | |
− | + | ||
− | + | <li><div class=width_small span style="cursor:default"><a>Team</a></div> | |
− | + | ||
− | + | ||
− | <li><div | + | |
<ul class="subs"> | <ul class="subs"> | ||
− | + | <li><a href="https://2015.igem.org/Team:NTU-LIHPAO-Taiwan/Team">Team</a></li> | |
− | <li><a href="https://2015.igem.org/Team:NTU-LIHPAO-Taiwan/ | + | <li><a href="https://2015.igem.org/Team:NTU-LIHPAO-Taiwan/Attributions">Attributions</a></li> |
− | + | ||
− | <li><a href="https://2015.igem.org/Team:NTU-LIHPAO-Taiwan/ | + | |
</ul> | </ul> | ||
</li> | </li> | ||
− | + | ||
− | <li><div | + | <li><div class=width_small span style="cursor:default"><a>Project</a></div> |
<ul class="subs"> | <ul class="subs"> | ||
− | <li><a href="https://2015.igem.org/Team:NTU-LIHPAO-Taiwan/ | + | <li><a href="https://2015.igem.org/Team:NTU-LIHPAO-Taiwan/Description">Description</a></li> |
− | <li><a href="https://2015.igem.org/Team:NTU-LIHPAO-Taiwan/ | + | <li><a href="https://2015.igem.org/Team:NTU-LIHPAO-Taiwan/Design">Design</a></li> |
− | <li><a href="https://2015.igem.org/Team:NTU-LIHPAO-Taiwan/Modeling/ | + | <li><a href="https://2015.igem.org/Team:NTU-LIHPAO-Taiwan/Results">Results</a></li> |
+ | <li><a href="https://2015.igem.org/Team:NTU-LIHPAO-Taiwan/Modeling">Modeling</a></li> | ||
+ | <li><a href="https://2015.igem.org/Team:NTU-LIHPAO-Taiwan/Experiments">Protocols</a></li> | ||
</ul> | </ul> | ||
</li> | </li> | ||
− | + | ||
− | <li><div | + | <li><div class=width_small span style="cursor:default"><div id=Position_Now><a>Parts</a></div></div> |
<ul class="subs"> | <ul class="subs"> | ||
− | <li><a href="https://2015.igem.org/Team:NTU-LIHPAO-Taiwan/ | + | <li><a href="https://2015.igem.org/Team:NTU-LIHPAO-Taiwan/Parts">Team Parts</a></li> |
− | <li><a href="https://2015.igem.org/Team:NTU-LIHPAO-Taiwan/ | + | <li><a href="https://2015.igem.org/Team:NTU-LIHPAO-Taiwan/Basic_Part">Basic Parts</a></li> |
+ | <li><a href="https://2015.igem.org/Team:NTU-LIHPAO-Taiwan/Composite_Part">Composite Parts</a></li> | ||
</ul> | </ul> | ||
</li> | </li> | ||
− | + | ||
− | <li><div | + | <li><div class=width_small><a href="https://2015.igem.org/Team:NTU-LIHPAO-Taiwan/Notebook">Notebook</a></div> |
</li> | </li> | ||
− | <li><div | + | <li><div class=width_small><a href="https://2015.igem.org/Team:NTU-LIHPAO-Taiwan/Safety">Safety</a></div> |
+ | </li> | ||
+ | |||
+ | <li><div class=width_small span style="cursor:default"><a>Society</a></div> | ||
<ul class="subs"> | <ul class="subs"> | ||
− | <li><a href=" | + | <li><a href="https://2015.igem.org/Team:NTU-LIHPAO-Taiwan/Practices">Human Practices</a></li> |
− | <li><a href=" | + | <li><a href="https://2015.igem.org/Team:NTU-LIHPAO-Taiwan/Collaborations">Collaborations</a></li> |
− | <li><a href=" | + | <li><a href="https://2015.igem.org/Team:NTU-LIHPAO-Taiwan/Entrepreneurship">Entrepreneurship</a></li> |
</ul> | </ul> | ||
</li> | </li> | ||
Line 577: | Line 797: | ||
</div> | </div> | ||
</div> | </div> | ||
− | + | ||
+ | <div id="Content_Container"> | ||
+ | <div id="Healthin_Logo_Content"><div id="Healthin_Logo"><img src="https://static.igem.org/mediawiki/2015/6/69/Healthin_White.png" style="max-width: 100%; height: auto"/></div></div> | ||
<div id="Content"> | <div id="Content"> | ||
<ul class="main-Content"> | <ul class="main-Content"> | ||
Line 589: | Line 811: | ||
<span class="title">Main Part</span> | <span class="title">Main Part</span> | ||
<ul class="sub-Content"> | <ul class="sub-Content"> | ||
− | <li><a href="#Second1">Part: | + | <li><a href="#Second1">Part:BBa_K1841001</a></li> |
− | <li><a href="#Second2">Part: | + | <li><a href="#Second2">Part:BBa_K1841004</a></li> |
− | <li><a href="#Second3">Part: | + | <li><a href="#Second3">Part:BBa_K1841007</a></li> |
</ul> | </ul> | ||
</li> | </li> | ||
Line 604: | Line 826: | ||
</li> | </li> | ||
<li> | <li> | ||
− | <span class="title"> | + | <span class="title">References</span> |
<ul class="sub-Content"> | <ul class="sub-Content"> | ||
− | <li><a href="#Fourth"> | + | <li><a href="#Fourth">References</a></li> |
</ul> | </ul> | ||
</li> | </li> | ||
</ul> | </ul> | ||
</div> | </div> | ||
+ | </div> | ||
+ | |||
<script> | <script> | ||
(function() { | (function() { | ||
Line 618: | Line 842: | ||
var sub_Content = main_Contents[i].querySelector(".sub-Content"); | var sub_Content = main_Contents[i].querySelector(".sub-Content"); | ||
if (i === index) { | if (i === index) { | ||
− | sub_Content.style.height = ' | + | sub_Content.style.height = '13rem'; |
} else { | } else { | ||
sub_Content.style.height = '0'; | sub_Content.style.height = '0'; | ||
Line 636: | Line 860: | ||
</script> | </script> | ||
− | |||
<div id="Articles"> | <div id="Articles"> | ||
<div class="ContentBox"> | <div class="ContentBox"> | ||
Line 645: | Line 868: | ||
The iGEM Team NTU-LIHPAO-Taiwan 2015 had built a new biological system for the iGEM community. The original design of the system making up the (Product) contains the three elements listed below, in a probiotic – <i>Lactobacillus casei</i> ATCC 393. | The iGEM Team NTU-LIHPAO-Taiwan 2015 had built a new biological system for the iGEM community. The original design of the system making up the (Product) contains the three elements listed below, in a probiotic – <i>Lactobacillus casei</i> ATCC 393. | ||
</div> | </div> | ||
+ | <div class="Container_Article_Picture1"> | ||
+ | <div class="Article_Picture1"> | ||
+ | <img src="https://static.igem.org/mediawiki/2015/a/a8/NTU_LASMID.jpg" width="368px"/> | ||
+ | <div class="Article_PictureText1"><div class="Text_Picture">[Fig.1-1] Designed Plasmid</div></div> | ||
+ | </div> | ||
+ | </div> | ||
+ | |||
<div class="Text1">Main Part</div> | <div class="Text1">Main Part</div> | ||
− | <div class="Text2" id="Second1">Part: | + | <div class="Text2" id="Second1">Part: BBa_K1841001</div> |
<div class="Text3"><div class="Text_TitleUnderline">nisI</div></div> | <div class="Text3"><div class="Text_TitleUnderline">nisI</div></div> | ||
<div class="Text3"> | <div class="Text3"> | ||
Research from Torsten <i>et al.</i> revealed that the highest level of acquired nisin tolerance was achieved after coordinated expression of all four nisin immunity genes, containing <i>nisI</i>, <i>nisF</i>, <i>nisE</i>, and <i>nisG</i>.<a href="#Reference1">[1]</a> Functional analyses provided evidence that NisI acts as a nisin-sequestering protein and that NisFEG acts as a nisin exporter that expels nisin molecules from the cytoplasmic membrane into the environment. | Research from Torsten <i>et al.</i> revealed that the highest level of acquired nisin tolerance was achieved after coordinated expression of all four nisin immunity genes, containing <i>nisI</i>, <i>nisF</i>, <i>nisE</i>, and <i>nisG</i>.<a href="#Reference1">[1]</a> Functional analyses provided evidence that NisI acts as a nisin-sequestering protein and that NisFEG acts as a nisin exporter that expels nisin molecules from the cytoplasmic membrane into the environment. | ||
</div> | </div> | ||
− | <div class=" | + | <div class="Container_Article_Picture"> |
− | <div class=" | + | <div class="Article_Picture"> |
− | <img src="https://static.igem.org/mediawiki/2015/3/34/NTU-Team-nisI.jpg" width=" | + | <img src="https://static.igem.org/mediawiki/2015/3/34/NTU-Team-nisI.jpg" width="480px"/> |
− | <div class=" | + | <div class="Article_PictureText"><div class="Text_Picture">[Fig.2-1] Nisin Selection</div></div> |
</div> | </div> | ||
</div> | </div> | ||
− | <div class="Text2" id="Second2">Part: | + | <div class="Text2" id="Second2">Part: BBa_K1841004</div> |
<div class="Text3"><div class="Text_TitleUnderline">plac promoter</div></div> | <div class="Text3"><div class="Text_TitleUnderline">plac promoter</div></div> | ||
<div class="Text3"> | <div class="Text3"> | ||
Line 663: | Line 893: | ||
The promoter region contains a cre element (catabolite responsive element) overlapping the –35 region, which is followed by a highly conserved sequence, the ribonucleic antiterminator (RAT) sequence, and a terminator structure. | The promoter region contains a cre element (catabolite responsive element) overlapping the –35 region, which is followed by a highly conserved sequence, the ribonucleic antiterminator (RAT) sequence, and a terminator structure. | ||
The antiterminator activity of LacT is also negatively controlled by glucose, possibly by PTS-mediated phosphorylation as explained below.<a href="#Reference2">[2]</a> | The antiterminator activity of LacT is also negatively controlled by glucose, possibly by PTS-mediated phosphorylation as explained below.<a href="#Reference2">[2]</a> | ||
− | <div class=" | + | <div class="Container_Article_Picture"> |
− | <div class=" | + | <div class="Article_Picture"> |
− | <img src="https://static.igem.org/mediawiki/2015/a/a4/NTU-Team-plac-cl.jpg" width=" | + | <img src="https://static.igem.org/mediawiki/2015/a/a4/NTU-Team-plac-cl.jpg" width="480px"/> |
− | <div class=" | + | <div class="Article_PictureText"><div class="Text_Picture">[Fig.2-2-1] Suicide Sense Part</div></div> |
</div> | </div> | ||
</div> | </div> | ||
− | <div class=" | + | <div class="Container_Article_Picture"> |
− | <div class=" | + | <div class="Article_Picture"> |
− | <img src="https://static.igem.org/mediawiki/2015/9/9a/NTU-Team-nuca.jpg" width=" | + | <img src="https://static.igem.org/mediawiki/2015/9/9a/NTU-Team-nuca.jpg" width="480px"/> |
− | <div class=" | + | <div class="Article_PictureText"><div class="Text_Picture">[Fig.2-2-2] Suicide Kill Part</div></div> |
</div> | </div> | ||
</div> | </div> | ||
− | + | <div class="Text2" id="Second3">Part: BBa_K1841007</div> | |
− | <div class="Text2" id="Second3">Part: | + | |
<div class="Text3"><div class="Text_TitleUnderline">TAT-PYY</div></div> | <div class="Text3"><div class="Text_TitleUnderline">TAT-PYY</div></div> | ||
<div class="Text3"> | <div class="Text3"> | ||
TAT can bring the big molecule substance like DNA, protein, peptide to penetrate the cell. Usually, named as protein transduction domain or membrane transduction domain, it is less than 40 amino acid.<a href="#Reference3">[3]</a> PYY belongs to the gastrointestinal hormones. Once the intestine detects the nutrition, the epidermal cell, L cell of ileum and colon will secrete the PYY. While the blood pass the hypothalamus, PYY will bind to the neuropeptide Y receptor in ventromedial nuclei causing the sense of satiation.<a href="#Reference4">[4]</a> | TAT can bring the big molecule substance like DNA, protein, peptide to penetrate the cell. Usually, named as protein transduction domain or membrane transduction domain, it is less than 40 amino acid.<a href="#Reference3">[3]</a> PYY belongs to the gastrointestinal hormones. Once the intestine detects the nutrition, the epidermal cell, L cell of ileum and colon will secrete the PYY. While the blood pass the hypothalamus, PYY will bind to the neuropeptide Y receptor in ventromedial nuclei causing the sense of satiation.<a href="#Reference4">[4]</a> | ||
</div> | </div> | ||
− | <div class=" | + | <div class="Container_Article_Picture"> |
− | <div class=" | + | <div class="Article_Picture"> |
− | <img src="https://static.igem.org/mediawiki/2015/6/6a/NTU-Team-tat-pyy-his.jpg" width=" | + | <img src="https://static.igem.org/mediawiki/2015/6/6a/NTU-Team-tat-pyy-his.jpg" width="480px"/> |
− | <div class=" | + | <div class="Article_PictureText"><div class="Text_Picture">[Fig.2-3] Cell penetrating peptide + PYY</div></div> |
</div> | </div> | ||
</div> | </div> | ||
Line 692: | Line 921: | ||
<div class="Text1">Test Part</div> | <div class="Text1">Test Part</div> | ||
<div class="Text2" id="Third1">RFP</div> | <div class="Text2" id="Third1">RFP</div> | ||
− | <div class=" | + | <div class="Container_Article_Picture"> |
− | <div class=" | + | <div class="Article_Picture"> |
− | <img src="https://static.igem.org/mediawiki/2015/4/4d/NTU-Team-plac-gfp.jpg" width=" | + | <img src="https://static.igem.org/mediawiki/2015/4/4d/NTU-Team-plac-gfp.jpg" width="480px"/> |
− | <div class=" | + | <div class="Article_PictureText"><div class="Text_Picture">[Fig.3-1] Suicide sense test</div></div> |
</div> | </div> | ||
</div> | </div> | ||
Line 702: | Line 931: | ||
</div> | </div> | ||
<div class="Text2" id="Third2">His-PYY</div> | <div class="Text2" id="Third2">His-PYY</div> | ||
− | <div class=" | + | <div class="Container_Article_Picture"> |
− | <div class=" | + | <div class="Article_Picture"> |
− | <img src="https://static.igem.org/mediawiki/2015/1/12/NTU-Team-his-pyy.jpg" width=" | + | <img src="https://static.igem.org/mediawiki/2015/1/12/NTU-Team-his-pyy.jpg" width="480px"/> |
− | <div class=" | + | <div class="Article_PictureText"><div class="Text_Picture">[Fig.3-2] PYY</div></div> |
</div> | </div> | ||
</div> | </div> | ||
Line 712: | Line 941: | ||
</div> | </div> | ||
<div class="Text2" id="Third3">Signal peptide-PYY-His</div> | <div class="Text2" id="Third3">Signal peptide-PYY-His</div> | ||
− | <div class=" | + | <div class="Container_Article_Picture"> |
− | <div class=" | + | <div class="Article_Picture"> |
− | <img src="https://static.igem.org/mediawiki/2015/3/39/NTU-Team-sp-pyy-his.jpg" width=" | + | <img src="https://static.igem.org/mediawiki/2015/3/39/NTU-Team-sp-pyy-his.jpg" width="480px"/> |
− | <div class=" | + | <div class="Article_PictureText"><div class="Text_Picture">[Fig.3-3] Signal peptide + PYY</div></div> |
</div> | </div> | ||
</div> | </div> | ||
Line 722: | Line 951: | ||
</div> | </div> | ||
<div class="Text2" id="Third4">Y2R</div> | <div class="Text2" id="Third4">Y2R</div> | ||
− | <div class=" | + | <div class="Container_Article_Picture"> |
− | <div class=" | + | <div class="Article_Picture"> |
− | <img src="https://static.igem.org/mediawiki/2015/e/ea/NTU-Team-y2r.jpg" width=" | + | <img src="https://static.igem.org/mediawiki/2015/e/ea/NTU-Team-y2r.jpg" width="480px"/> |
− | <div class=" | + | <div class="Article_PictureText"><div class="Text_Picture">[Fig.3-4] Y2R</div></div> |
</div> | </div> | ||
</div> | </div> | ||
Line 731: | Line 960: | ||
In this part, we use the constitutive promoter BBa_J23100 to produce Y2R. This part is constructed to verify the function of PYY. | In this part, we use the constitutive promoter BBa_J23100 to produce Y2R. This part is constructed to verify the function of PYY. | ||
</div> | </div> | ||
− | <div class="Text1"> | + | <div class="Text1">References</div> |
− | <div class="Text2" id="Fourth"> | + | <div class="Text2" id="Fourth">References</div> |
<div class="Text3" id="Reference1"> | <div class="Text3" id="Reference1"> | ||
[1] Torsten, S., Stefan, H., Irina, S., and K. D. Entian. Function of Lactococcus lactis Nisin Immunity Genes nisI and nisFEG after Coordinated Expression in the Surrogate Host Bacillus subtilis. The Jurnal of Biological Chemistry, USA. , Vol. 278, pp. 89 -94 (2003) | [1] Torsten, S., Stefan, H., Irina, S., and K. D. Entian. Function of Lactococcus lactis Nisin Immunity Genes nisI and nisFEG after Coordinated Expression in the Surrogate Host Bacillus subtilis. The Jurnal of Biological Chemistry, USA. , Vol. 278, pp. 89 -94 (2003) | ||
Line 741: | Line 970: | ||
<div class="Text3" id="Reference3"> | <div class="Text3" id="Reference3"> | ||
[3] Ju-Chen Cheng, 2009, Investigation on the Characteristic of Heparin-Binding Haemagglutinin 3 Adhesin (HBHA)-Related Peptides and their Transcytosis | [3] Ju-Chen Cheng, 2009, Investigation on the Characteristic of Heparin-Binding Haemagglutinin 3 Adhesin (HBHA)-Related Peptides and their Transcytosis | ||
+ | </div> | ||
+ | <div class="Text3" id="Reference4"> | ||
+ | [4] C. W. le Roux and S. R. Bloom. Peptide YY, appetite and food intake.(2005) | ||
+ | </div> | ||
+ | |||
+ | <div class="Container_Bottom1"></div> | ||
+ | <div class="Container_Bottom2"> | ||
+ | <div class="Intro_Picture"> | ||
+ | <div id="NTUschool_logo"><a href="http://www.ntu.edu.tw/english/index.html"><img src="https://static.igem.org/mediawiki/2015/d/de/NTUschool_icon.png" style="max-width: 100%; max-height: 70px"/></a></div> | ||
+ | <div id="LIHPAO_logo"><a href="http://www.llsc.com.tw/"><img src="https://static.igem.org/mediawiki/2015/d/d4/LIHPAO_logo.png" style="max-width: 100%; max-height: 70px"/></a></div> | ||
+ | <div id="NTUBST_logo"><a href="http://www.bst.ntu.edu.tw/BST-new/NTUBST.html"><img src="https://static.igem.org/mediawiki/2015/6/68/NTUBST_logo.png" style="max-width: 100%; max-height: 70px"/></a></div> | ||
+ | </div> | ||
+ | </div> | ||
+ | <div class="Text_Sponsor"> | ||
+ | Maintained by the iGEM team NTU-LIHPAO-Taiwan ©2015 NTU-LIHPAO-Taiwan | ||
</div> | </div> | ||
</div> | </div> |
Latest revision as of 13:19, 18 September 2015
- Prototype
- Main Part
- Test Part
- References
Prototype
Prototype
The iGEM Team NTU-LIHPAO-Taiwan 2015 had built a new biological system for the iGEM community. The original design of the system making up the (Product) contains the three elements listed below, in a probiotic – Lactobacillus casei ATCC 393.
[Fig.1-1] Designed Plasmid
Main Part
Part: BBa_K1841001
nisI
Research from Torsten et al. revealed that the highest level of acquired nisin tolerance was achieved after coordinated expression of all four nisin immunity genes, containing nisI, nisF, nisE, and nisG.[1] Functional analyses provided evidence that NisI acts as a nisin-sequestering protein and that NisFEG acts as a nisin exporter that expels nisin molecules from the cytoplasmic membrane into the environment.
[Fig.2-1] Nisin Selection
Part: BBa_K1841004
plac promoter
Lactose operon of Lactobacillus casei In Lactobacillus casei ATCC393 [pLZ15–], the lactose genes are grouped in a cluster transcribed as single operon. The cluster lacTEGF encodes an antiterminator protein (LacT), lactose-specific elements (LacE and LacF) of the phosphotransferase system (PTS) and a phospho-β-galactosidase (LacG).
The promoter region contains a cre element (catabolite responsive element) overlapping the –35 region, which is followed by a highly conserved sequence, the ribonucleic antiterminator (RAT) sequence, and a terminator structure.
The antiterminator activity of LacT is also negatively controlled by glucose, possibly by PTS-mediated phosphorylation as explained below.[2]
[Fig.2-2-1] Suicide Sense Part
[Fig.2-2-2] Suicide Kill Part
Part: BBa_K1841007
TAT-PYY
TAT can bring the big molecule substance like DNA, protein, peptide to penetrate the cell. Usually, named as protein transduction domain or membrane transduction domain, it is less than 40 amino acid.[3] PYY belongs to the gastrointestinal hormones. Once the intestine detects the nutrition, the epidermal cell, L cell of ileum and colon will secrete the PYY. While the blood pass the hypothalamus, PYY will bind to the neuropeptide Y receptor in ventromedial nuclei causing the sense of satiation.[4]
[Fig.2-3] Cell penetrating peptide + PYY
In this part, we use the constitutive promoter BBa_J23100 to produce signal peptide-PYY-histidine fusion protein. With the His-tag, we can easily purify the signal peptide-PYY from other non-His-tag protein. This part is constructed to test the amount of the PYY that can secret out of the L. casei.
Test Part
RFP
[Fig.3-1] Suicide sense test
In this part, we use the RFP protein to testify the function of the lactose operon.
His-PYY
[Fig.3-2] PYY
In this part, we use the constitutive promoter BBa_J23100 to produce histidine-PYY fusion protein. With the His-tag, we can easily purify the PYY from other non-His-tag protein. This part is constructed to test the amount of the PYY under the constitutive promoter in the L. casei.
Signal peptide-PYY-His
[Fig.3-3] Signal peptide + PYY
In this part, we use the constitutive promoter BBa_J23100 to produce signal peptide-PYY-histidine fusion protein. With the His-tag, we can easily purify the signal peptide-PYY from other non-His-tag protein. This part is constructed to test the amount of the PYY that can secret out of the L. casei.
Y2R
[Fig.3-4] Y2R
In this part, we use the constitutive promoter BBa_J23100 to produce Y2R. This part is constructed to verify the function of PYY.
References
References
[1] Torsten, S., Stefan, H., Irina, S., and K. D. Entian. Function of Lactococcus lactis Nisin Immunity Genes nisI and nisFEG after Coordinated Expression in the Surrogate Host Bacillus subtilis. The Jurnal of Biological Chemistry, USA. , Vol. 278, pp. 89 -94 (2003)
[2] Yu-Kuo Tsai, Hung- Wen Chen, Ta-Chun Lo and Thy-Hou Lin. Specific point mutation in Lactobacillus casei ATCC 27139 cause the phenotype switch from Lac- to Lac+. Microbiology, pp. 751-760(2009)
[3] Ju-Chen Cheng, 2009, Investigation on the Characteristic of Heparin-Binding Haemagglutinin 3 Adhesin (HBHA)-Related Peptides and their Transcytosis
[4] C. W. le Roux and S. R. Bloom. Peptide YY, appetite and food intake.(2005)
Maintained by the iGEM team NTU-LIHPAO-Taiwan ©2015 NTU-LIHPAO-Taiwan